The themes Quest Diagnostics is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Les parts du chiffre d'affaires sont des estimations pour three months ended June 30, 2026, pas des chiffres tirés d'un document officiel.
Routine and non-routine clinical laboratory tests
Tests of blood, urine and other samples, including common checks of blood counts, organ function, allergies and infections, as well as more specialized tests.
Advanced diagnostic tests
Specialized tests in areas such as cancer, genetics, brain health and autoimmune disease. Examples include blood tests for Alzheimer’s disease risk and Haystack testing for signs of remaining or returning cancer.
Anatomic pathology
Examination of tissue and cell samples to help diagnose cancer and other diseases.
Collaborative Lab Solutions
Services that help hospitals manage their laboratories, choose tests, control supply costs and use laboratory data.
QuestHealth.com
A website where people can buy health and wellness tests, with physician review of test orders and the option to discuss results with a physician.
ExamOne
Examinations, sample testing and information gathering that help life insurers assess insurance applicants.
Quest Diagnostics collects and tests blood, urine, tissue and other samples, then provides results that help healthcare professionals diagnose, monitor and treat medical conditions. It also performs tests that hospitals send to outside laboratories, helps hospitals run their own labs, and offers testing and data services to insurers and other organizations. It processed 244 million test requisitions (2025, high).
Construit à partir des documents déposés par Quest Diagnostics Inc. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.
259,69 $US0,0 %clôture 13 nov.
Chiffres jusqu’au 30 septembre 2026, issus du 10-Q déposé le 23 octobre 2026
Quest Diagnostics performs medical tests on blood and other samples for doctors, hospitals, health plans and patients.
Prévision de l’entreprise : chiffre d’affaires de de 12,1B $US à 12,1B $US pour Exercice 2026 — en hausse de 9,5 % sur un an
Grade A
La bande sous le cours montre la note à chaque date, établie uniquement à partir des documents publics à ce moment-là.
Affichage de 2 trimestres sur 40 de l’historique des notes de Quest Diagnostics Inc.. Les 38 autres remontent jusqu’à février 2017.